1-20 of 1,840 results for subject:Contraceptives
Librarians' tools
- Search time
- 0.254 seconds
- Solr query time
- 0.007 seconds
- Search query
- subject:Contraceptives
- We searched for
- subject_t:Contraceptives OR subject_t:Contraception OR subject_t:"Morning after pill" OR subject_t:"Oral contraceptives" OR subject_ses:90708
Type
House
Session
More
Year
More
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, when the Medicines and Healthcare products Regulatory Agency expects to publish its research comparing the risk of meningioma associated with Depo-Provera and other contraceptives.
To ask the Secretary of State for Health and Social Care, when the Medicines and Healthcare products Regulatory Agency expects to publish its research comparing the risk of meningioma associated with Depo-Provera and other contraceptives.
The Medicines and Healthcare products Regulatory Agency (MHRA) expects to complete its review of the risk of meningioma associated with Depo-Provera and other contraceptives using data from the Clinical Practice Research Datalink in June 2028. The MHRA will seek to publish the findings in peer-reviewed journals once the analysis is complete.
To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency plans to examine the impact of Depo-Provera use on trends in meningioma diagnoses.
To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency plans to examine the impact of Depo-Provera use on trends in meningioma diagnoses.
I refer the Hon Member to the answer provided on 9 September in response to Question 21794.
To ask the Secretary of State for Health and Social Care, what consideration she has given to the potential impact of the use of Depo-Provera on trends in the level of meningioma.
To ask the Secretary of State for Health and Social Care, what consideration she has given to the potential impact of the use of Depo-Provera on trends in the level of meningioma.
The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care and regulates medicine, medical devices and blood components for transfusion in the United Kingdom, with responsibility for ensuring medicines meet appropriate standards of safety, quality, and efficacy.
Depo-Provera is an effective injectable contraceptive which contains medroxyprogesterone acetate (MPA), a synthetic form of progesterone, and provides 12 weeks of contraception.
Meningiomas are generally non-cancerous (benign) brain tumours which affect the meninges, the thin layer of tissue surrounding the brain and spinal cord. In recent years, meningioma has rarely been associated with long-term use of high doses of some synthetic forms of progesterone, including cyproterone acetate and nomegestrol.
The MHRA has not examined the impact of Depo-Provera use on trends in meningioma diagnoses. However, the product information for Depo-Provera was updated after a study published in 2024 showed an excess risk of meningioma with high dose MPA. The marketing authorisation holder subsequently wrote to UK healthcare professionals with updated advice on managing this risk. Additional studies have since confirmed the association, and the MHRA is conducting research using UK Clinical Practice Research Datalink data to compare the risks of meningioma, fracture and osteoporosis associated with injectable depot MPA and other contraceptives.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether UK aid funding is being used to fund depo Provera contraceptive injections.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether UK aid funding is being used to fund depo Provera contraceptive injections.
Through UK-funded programmes, including Women's Integrated Sexual Health-Dividend (WISH-Dividend) and support to the United Nations Population Fund (UNFPA) Supplies Partnership, the Foreign, Commonwealth and Development Office helps expand access globally to a range of contraceptive methods, including Depo Provera contraceptive injections (DMPA).
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help increase the provision of contraceptive services.
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help increase the provision of contraceptive services.
The Government provides funding for contraception, both as an essential service which general practices (GPs) must either provide or arrange for the provision of to their patients through the GP Contract, and through the Public Health Grant to local authorities.
Local authorities across England are responsible for commissioning comprehensive, open access sexual and reproductive health services, including contraception, to meet local demand, and it is for them to decide on commissioning arrangements based on an assessment of local need.
To offer greater choice in how people can access contraception services, the NHS Pharmacy Contraception Service has been introduced. This enables pharmacists to issue ongoing supplies of contraception initiated in GP surgeries and sexual health services and to initiate oral contraception. Since October 2025, Emergency Hormonal Contraception forms part of the Pharmacy Contraception Service, which means women have access to the morning-after pill free of charge from pharmacies.
However, there is more to do. In the Renewed Women’s Health Strategy, published on 15 April 2026, we have set out our commitment to improve access to contraception through seamless contraception pathways, with closer working between National Health Services and local authorities to reduce fragmentation. The renewed strategy also commits to simpler, faster access to the full range of contraception, including through community, pharmacy, and digital routes.
In addition, we will include contraception in the upcoming sexual and reproductive health framework to clarify current commissioning arrangements and share opportunities and best practice for closer working and improved pathways.
To ask the Secretary of State for Health and Social Care, how many times female prisoners have been provided with an emergency contraceptive pill in the past two years.
To ask the Secretary of State for Health and Social Care, how many times female prisoners have been provided with an emergency contraceptive pill in the past two years.
Although NHS England does not hold this information either nationally or regionally, access to emergency oral hormonal contraception is available at all female prisons; and healthcare professionals should provide information and advice about the full range of contraceptive methods and offer to prescribe a contraceptive substance or appliance prior to discharge.
All prison healthcare has access to pharmacy and dispensing services, as this forms part of the service specification and is a contractual requirement. All healthcare services including access to emergency oral contraception are funded by NHS England.
A summary of reproductive health service statistics in England, including contraception, conceptions, abortions, and cervical screening.
A summary of reproductive health service statistics in England, including contraception, conceptions, abortions, and cervical screening.
To ask the Secretary of State for Health and Social Care, what (i) steps his department is taking to address regional differences in funding for Mirena coil fitting and (ii) if he plans to ensure this service is available at GP surgeries.
To ask the Secretary of State for Health and Social Care, what (i) steps his department is taking to address regional differences in funding for Mirena coil fitting and (ii) if he plans to ensure this service is available at GP surgeries.
The funding and provision of long-acting reversible contraception (LARC), such as the Mirena coil, is primarily a matter for local determination.
Integrated care boards (ICBs) are responsible for commissioning contraception for both contraceptive and gynaecological purposes, including essential services under the GP Contract and LARC as a local arrangement.
Contraception for contraceptive purposes, including LARC, is also a prescribed aspect of local authority sexual health commissioning. The Government has mandated local authorities in England to commission comprehensive open access to most sexual and reproductive health services through the Public Health Grant.
It is for individual local authorities and ICBs to decide their spending priorities based on an assessment of local need, and to commission the blend of service access that best suits their population.
The renewed Women’s Health Strategy, which was published on 15 April, sets out how we will ensure that women have straightforward access to the full range of contraception, including LARC, that meets their individual needs and preferences.
We will include contraception in the upcoming sexual and reproductive health framework to clarify current commissioning arrangements and to share opportunities and best practice for closer working and improved pathways.
Motion that this House has considered the identification and prosecution of reproductive coercion. Agreed to on question.
Motion that this House has considered the identification and prosecution of reproductive coercion. Agreed to on question.
I beg to move,
That this House has considered the identification and prosecution of reproductive coercion.
We have all heard the narrative about the devious woman who gets pregnant to get what she wants: “She’s got pregnant to trap him. She’s after his money.” That was what I heard on loop from...
I beg to move,
That this House has considered the identification and prosecution of reproductive coercion.
We have all heard the narrative about the devious woman who gets pregnant to get what she wants: “She’s got pregnant to trap him. She’s after his money.” That was what I heard on loop from...
We have all heard the narrative—the one where the devious woman gets pregnant to trap the man: “She’s only after his money. She just wants to trap him.” That was what I heard on loop when I was impregnated as a child. If anyone questioned why he, an older man...
We have all heard the narrative—the one where the devious woman gets pregnant to trap the man: “She’s only after his money. She just wants to trap him.” That was what I heard on loop when I was impregnated as a child. If anyone questioned why he, an older man...
My hon. Friend is telling an incredibly powerful story about reproductive coercion and, in particular, the role of family courts. Does she agree that this issue, this case and all the matters that it brings to light would be perfect for the review of family courts that Baroness Levitt has...
My hon. Friend is telling an incredibly powerful story about reproductive coercion and, in particular, the role of family courts. Does she agree that this issue, this case and all the matters that it brings to light would be perfect for the review of family courts that Baroness Levitt has...
Absolutely; I think that this is something that we need to shine a light on however we can. Far too many women are traumatised by family courts in this way—the situation is absolutely ripe for intervention.
Absolutely; I think that this is something that we need to shine a light on however we can. Far too many women are traumatised by family courts in this way—the situation is absolutely ripe for intervention.
I commend the hon. Lady for bringing forward this issue. She has strength of character, strength of personality and commitment to these subjects; it is always a pleasure to come along and hear her express her viewpoint, and I congratulate her. Just to be helpful to her—I did speak to...
I commend the hon. Lady for bringing forward this issue. She has strength of character, strength of personality and commitment to these subjects; it is always a pleasure to come along and hear her express her viewpoint, and I congratulate her. Just to be helpful to her—I did speak to...
I absolutely agree; the hon. Member makes very good points that I did not know about. The more we can talk about this issue, the better, and making it a stand-alone offence is absolutely the right thing to do.
It is easy to dismiss Liv’s as a story of extreme wealth,...
I absolutely agree; the hon. Member makes very good points that I did not know about. The more we can talk about this issue, the better, and making it a stand-alone offence is absolutely the right thing to do.
It is easy to dismiss Liv’s as a story of extreme wealth,...
It is a pleasure to serve with you in the Chair, Mr Dowd. I thank my hon. Friend the Member for Bolsover (Natalie Fleet) for bringing forward this really important debate. To echo the hon. Member for Strangford (Jim Shannon), she always uses her voice in this place to amplify...
It is a pleasure to serve with you in the Chair, Mr Dowd. I thank my hon. Friend the Member for Bolsover (Natalie Fleet) for bringing forward this really important debate. To echo the hon. Member for Strangford (Jim Shannon), she always uses her voice in this place to amplify...
I thank the Minister for her positive response to the hon. Member for Bolsover (Natalie Fleet). The Minister obviously understands the issue very clearly. In my earlier intervention, I gave the example of Northern Ireland, where the sentence for coercive behaviour is 14 years. Over here on the mainland, in...
I thank the Minister for her positive response to the hon. Member for Bolsover (Natalie Fleet). The Minister obviously understands the issue very clearly. In my earlier intervention, I gave the example of Northern Ireland, where the sentence for coercive behaviour is 14 years. Over here on the mainland, in...
I thank the hon. Gentleman for raising the distinction in the sentencing for this crime in Northern Ireland. In England and Wales, the sentence is a maximum of five years, but as I have said, the crime normally comes alongside other forms of abuse, for which the CPS will look...
I thank the hon. Gentleman for raising the distinction in the sentencing for this crime in Northern Ireland. In England and Wales, the sentence is a maximum of five years, but as I have said, the crime normally comes alongside other forms of abuse, for which the CPS will look...
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that commitments within the Women’s Health Strategy refresh are implemented equitably to improve access to contraception at a local level.
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that commitments within the Women’s Health Strategy refresh are implemented equitably to improve access to contraception at a local level.
The Government is committed to ensuring equitable access to a range of contraceptive methods including long-acting reversible contraception.
The renewed women’s health strategy will set out how the Government will take the next steps to improve women's healthcare as part of the 10-Year Health Plan and create a system that listens to women, including consideration of barriers to access. Steps to improve access to contraception are being considered as part of the renewal.